Last Updated: October 24th, 2025
We develop global value propositions by conducting payer research, gap analyses, and targeted literature reviews. We also align with internal teams to create evidence generation plans that optimize market access.
What Is a Global Value Proposition?
A global value proposition is a unified narrative of clinical, economic, and real-world benefits tailored for payers across markets. It aims to identify what evidence is needed, what messages resonate, and how to adapt across jurisdictions to support reimbursement and access.
How Our Technology Delivers Results
We combine technical expertise with deep healthcare strategy and clinical insights, brought to every project by our team of experts. Our services include:
- Targeted literature review: We analyzed competitor trials, prior HTA submissions, and analog products.
- Gap analysis: We evaluated the existing evidence base and identified gaps relative to therapeutic area access requirements.
- Primary research: We recruited 18 payers across the US, UK, Germany, Spain, Italy, and France to validate the value proposition and evidence plan.
How Our Practical Agility Keeps Teams Ahead
Our lean, flexible approach enables seamless teamwork and quick mobilization of resources, ensuring projects move forward efficiently without unnecessary hurdles. Our work includes:
- Internal stakeholder interviews: Facilitated discussions with client teams across R&D, pricing, medical affairs, and HEOR to align on objectives and evidence needs.
- Key value message testing: Gathered payer perspectives on critical clinical and economic evidence requirements within a competitive landscape.
- Payer insights and objection analysis: Collected and synthesized comprehensive feedback on payer perceptions, potential objections, and barriers to market access.
- Evidence generation plan: Designed a targeted evidence generation strategy to support optimal market access in each relevant country.
Customer Testimonies
Why a Strong Global Value Proposition Matters
It ensures messaging aligns with payer expectations around benefit, risk, and economic value. A strong value proposition exposes evidence gaps early so plans can proactively address them. It aligns internal stakeholders (clinical, HEOR, pricing, market access) around a cohesive narrative. It differentiates the therapy in competitive landscapes, as well as globally.
A Step Forward in Value Communication
Our Market Access team helps turn this value proposition into actionable strategies. We guide evidence generation, support payer engagement, and plan for access to achieve optimal reimbursement across global markets. By leveraging our global experience, we ensure strategies are tailored to the unique requirements of each country, maximizing the likelihood of successful market entry.
Is your therapy’s value clearly resonating with payers across every market?
Meet our Value Communication Team
Mike Blackney
Head of Operations
Mike is responsible for overseeing operational strategies at FIECON, ensuring the delivery of first-class results and client satisfaction. With more than fifteen years of experience in market access and pricing, Mike has worked with leading global pharmaceutical companies on key access-based projects. His previous roles include senior positions at Covance Market Access and as a Research Scientist, where he contributed significantly to pharmaceutical strategy.
Susan Suponcic
Strategic Council Member
Susan is a market access executive with over 25 years of experience in pricing, health economics, and market access roles across both corporate and consulting environments. She has successfully led market access strategies for global launches in virology and oncology, delivering over $3 billion in revenues in under five years. Throughout her career, Susan has made significant contributions to patient advocacy and policy recognition, playing a pivotal role in corporate responsibility initiatives that have influenced major US healthcare reforms.
Will Wright
Associate Director
Will brings over 10 years of experience in leading strategic HEOR and market access projects. He has directed multiple HTA submissions, PRMA strategies, payer research, and global value propositions across the pharmaceutical and biotech industries. Will specializes in digital solutions for value communication and has led high-impact projects for major global companies.
FAQs on Global Value Proposition
- When is the right time to develop a global value proposition?
Clinical, regulatory, and evidence plans can be aligned even in early development stages, before pivotal trials. - Who should be involved?
Internal stakeholders (R&D, HEOR, medical affairs, pricing) plus external payer or reimbursement experts to validate messaging. - What is the role of gap analysis?
To pinpoint where evidence is weak or insufficient relative to payer/reimbursement expectations and guide what needs to be generated. - How do payer interviews help?
They validate how payers perceive value, what clinical or economic evidence they demand, and what objections may arise. - What are typical deliverables?
Value messaging frameworks, payer feedback reports, country-specific evidence plans, and alignment workshops.